DENR inhibitors, particularly those targeting Density-Regulated Protein directly, are not widely documented in the context of direct chemical inhibition. However, understanding the potential indirect inhibition of DENR involves considering its role in non-canonical translation initiation and its involvement in stress responses and cellular proliferation. The chemicals listed above target various aspects of translation initiation and cellular signaling, thereby potentially influencing the role of DENR. Compounds like Rapamycin, Silvestrol, and Rocaglamide target key components of the translation initiation machinery, such as mTOR and eIF4A. These inhibitors could indirectly impact DENR by disrupting the overall process of translation initiation, where DENR plays a critical role. 4E1RCat, which inhibits the eIF4E-eIF4G interaction, could similarly influence translation initiation processes involving DENR.
Inhibitors like LY 294002 and Wortmannin target the PI3K/Akt signaling pathway, which is involved in various cellular processes including translation regulation. By modulating these pathways, these compounds could indirectly affect DENR's activity or stability. MEK inhibitors, such as U0126 and PD 98059, could also impact signaling pathways influencing DENR expression or its function in translation initiation. Staurosporine, a broad-spectrum kinase inhibitor, and Cycloheximide, a well-known inhibitor of eukaryotic protein synthesis, can also influence DENR's role in translation. Homoharringtonine, which inhibits the initial step of translation elongation, and Anisomycin, which affects peptide bond formation, further demonstrate the indirect methods by which translation initiation, and thereby DENR's function, can be modulated. In summary, while direct inhibitors of DENR are not well-characterized, these compounds offer potential indirect methods to influence DENR activity. They act by inhibiting different stages of translation initiation or affecting signaling pathways and cellular processes related to DENR's function. This approach is critical in studies focusing on the mechanisms of non-canonical translation initiation and the role of DENR in cellular stress responses and proliferation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of translation initiation, potentially influencing DENR's role in non-canonical initiation events. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Silvestrol, an inhibitor of eIF4A, can affect translation initiation, potentially impacting DENR's function in mRNA translation. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Similar to Silvestrol, Rocaglamide targets eIF4A and could indirectly affect DENR's role in translation initiation. | ||||||
4E1RCat | 328998-25-0 | sc-361085 sc-361085A | 10 mg 50 mg | $193.00 $813.00 | ||
4E1RCat inhibits eIF4E-eIF4G interaction, potentially influencing translation initiation processes involving DENR. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a PI3K inhibitor, potentially altering signaling pathways that could indirectly modulate DENR activity or stability. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a kinase inhibitor, could affect various signaling pathways, potentially influencing DENR's function. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis, potentially affecting DENR's role in translation initiation. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
This compound inhibits protein synthesis by preventing the initial elongation step, potentially impacting DENR. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor like LY 294002, could indirectly affect DENR through modulation of PI3K/Akt signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin inhibits peptide bond formation and can affect mRNA decoding, potentially impacting DENR's role in translation. | ||||||